References
- Kirby JS, Miller JJ, Adams DR, et al. Health care utilization patterns and costs for patients with hidradenitis suppurativa. JAMA Dermatol. 2014;150:937–944.
- Khalsa A, Liu G, Kirby JS. Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa. J Am Acad Dermatol. 2015;73:609–614.
- Tirell M. Johnson & Johnson lifts lid on drug pricing data, shows 3.5% net hike in 2016: CNBC; 2017. [updated 2017 Feb 27; 2018 May 26]. Available from: https://www.cnbc.com/2017/02/27/johnson-johnson-lifts-lid-on-drug-pricing-data-shows-35-net-hike-in-2016.html
- Methodology for Calculating the National Average Drug Acquisition Cost (NADAC) for Medicaid Covered Outpatient Drugs. Centers for Medicare & Medicaid Services. 2013. [updated 2018 May 26]. Available from: https://www.medicaid.gov/medicaid-chip-program-information/by-topics/prescription-drugs/ful-nadac-downloads/nadacmethodology.pdf
- Curtiss FR, Lettrich P, Fairman KA. What is the price benchmark to replace average wholesale price (AWP)? J Manag Care Pharm. 2010;16:492–501.
- Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619–644.
- Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375:422.
- Drug Trend Report. Express Scripts. 2016. [updated 2018 May 26]. Available from: http://lab.express-scripts.com/lab/drug-trend-report/previous-reports
- Beyer V, Wolverton SE. Recent trends in systemic psoriasis treatment costs. Arch Dermatol. 2010;146:46–54.
- Alpern JD, Zhang L, Stauffer WM, et al. Trends in pricing and generic competition within the oral antibiotic drug market in the United States. Clin Infect Dis. 2017;65:1848–1852.
- Dave CV, Kesselheim AS, Fox ER, et al. High generic drug prices and market competition. Ann Intern Med. 2017;167:145–151.
- Yang EJ, Beck KM, Sekhon S, et al. Pharmacy costs of specialty medications for plaque psoriasis in the United States. J Am Acad Dermatol. 2018;pii: S0190–9622(18)30563–2.
- Cuckler GA, Sisko AM, Poisal JA, et al. National health expenditure projections, 2017–26: despite uncertainty, fundamentals primarily drive spending growth. Health Aff (Millwood). 2018;37:482–492.
- Schumock GT, Li EC, Wiest MD, et al. National trends in prescription drug expenditures and projections for 2017. Am J Health Syst Pharm. 2017;74:1158–1173.